Oral anticoagulation for stroke prevention amongst atrial fibrillation patients with valvular heart disease: an update
Atrial fibrillation patients with concomitant valvulopathies constitute a group with high
thromboembolic risk and should be treated with oral anticoagulation. There is good …
thromboembolic risk and should be treated with oral anticoagulation. There is good …
Oral anticoagulation for stroke prevention amongst atrial fibrillation patients with valvular heart disease: an update
ACT Ha, A Verma, S Verma - Current Opinion in Cardiology, 2017 - ingentaconnect.com
Purpose of review The majority of evidence on the safety and efficacy of oral anticoagulation
for stroke prevention amongst patients with atrial fibrillation is derived from those without …
for stroke prevention amongst patients with atrial fibrillation is derived from those without …
Oral anticoagulation for stroke prevention amongst atrial fibrillation patients with valvular heart disease: an update
ACT Ha, A Verma, S Verma - Current opinion in …, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose of review The majority of evidence on the safety and efficacy of oral anticoagulation
for stroke prevention amongst patients with atrial fibrillation is derived from those without …
for stroke prevention amongst patients with atrial fibrillation is derived from those without …
Oral anticoagulation for stroke prevention amongst atrial fibrillation patients with valvular heart disease: an update.
AC Ha, A Verma, S Verma - Current Opinion in Cardiology, 2017 - europepmc.org
Atrial fibrillation patients with concomitant valvulopathies constitute a group with high
thromboembolic risk and should be treated with oral anticoagulation. There is good …
thromboembolic risk and should be treated with oral anticoagulation. There is good …